Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France

University Hospital, Lille6 sites in 1 country901 target enrollmentApril 15, 2020

ConditionsCoronavirus COVID Infection Viral

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Coronavirus
Sponsor: University Hospital, Lille
Enrollment: 901
Locations: 6
Primary Endpoint: Prevalence of positivity of COVID-19 virus measured by rt-PCR
Status: Completed
Last Updated: 5 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Arriving in December 2019, Coronavirus COVID-19 infection is causing a global pandemic with high morbidity and mortality among adults and especially seniors. The child appears little or no affected by this infection. It is estimated that the child could be asymptomatic or pauci-symptomatic carrier and thus be vector of the disease. For this reason, measures have been taken to close schools and contain populations in a large number of countries, including France. However, there are no data on the prevalence of COVID-19 in children.

Registry

clinicaltrials.gov

Start Date

April 15, 2020

End Date

January 1, 2021

Last Updated

5 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

University Hospital, Lille

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•1st Line Consultation in Pediatric Emergencies
•All reasons for consultation during working hours
•Informed and written consent of a parent holder (only 1 authorized companion) and a child of understanding age

Exclusion Criteria

•Refusal of participation by parents/child of decision age
•No membership of a social security scheme (beneficiary or entitled)
•No understanding of French

Outcomes

Primary Outcomes

Prevalence of positivity of COVID-19 virus measured by rt-PCR

Time Frame: At 28 days

Secondary Outcomes

Percentage of children hospitalized tested within 28 day(through study completion, an average 28 days)
Respiratory signs of children tested within 28 day(through study completion, an average 28 days)
Contact frequency(At inclusion)
Prevalence of positivity of other respiratory viruses measured by rt-PCR(at 28 days)
Prevalence of positivity of COVID-19 virus measured by rt-PCR in the following subpopulations of emergency patients(at the end an average 28 days)